Developing the role of pharmacists as members of community mental health teams: Perspectives of pharmacists and mental health professionals

Bell, J. Simon; Rosen, Alan; Aslani, Parisa; Whitehead, Paula; Chen, Timothy

doi:10.1016/j.sapharm.2006.10.005

Cited by 53 publications

(55 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data were extracted from nine controlled studies (Table 1), 20-28 34 observational or uncontrolled studies with a focus on MRPs (Table 2), [29][30][31][32][33][34][35][36][37][38][39][40][41][42][43] and other clinical, humanistic and economic outcomes (Table 3), 10,44-61 11 qualitative (including interviews and focus groups) and nine survey research studies (Table 4). 11,13,[62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79] Methodological quality of studies…”

Section: Resultsmentioning

confidence: 99%

“…21,23,24,26,27 It was not explicitly stated if outcome assessors were blinded in 89% (n ¼ 8) [20][21][22][24][25][26][27][28] of controlled studies and this quality criterion was unmet in one study. 23 All qualitative studies (n ¼ 11) 11,13,63,65,68,73,74,76,78,79 had good congruity between the research methodology and their research question, data collection, data analysis and interpretation of results. The position of the researcher or their influence on study results was not explicitly stated in seven studies.…”

Section: Resultsmentioning

confidence: 99%

“…This included CMRs which involved pharmacist 22,44,53 Findings of qualitative work also supported these referral pathways, with stakeholders highlighting the use of pharmacists, nursing staff and other health providers as sources for CMR referrals. 63,64 Studies also reported CMRs undertaken by an accredited pharmacist working in a medical practice, 10,33,42,45 or as part of an ACAT (n ¼ 2), 23,51 community mental health team (n ¼ 1), 35,63 or palliative care team (n ¼ 1). 36 Six studies involved face-to-face case-conferences between the GP and pharmacist after CMR.…”

Section: Participant Characteristicsmentioning

confidence: 99%

See 2 more Smart Citations

Clinical medication review in Australia: A systematic review

Jokanovic

Tan

Bosch

et al. 2016

Research in Social and Administrative Pharmacy

Self Cite

110

122

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Participant Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical medication review in Australia: A systematic review

Jokanovic

Tan

Bosch

et al. 2016

Research in Social and Administrative Pharmacy

Self Cite

110

122

View full text Add to dashboard Cite

“…They found that over 80% of respondents felt that pharmacists should help with the selection of the appropriate antibiotic, advice regarding which is the most appropriate medication, and make medication decisions on the basis of medication pricing or efficacy. The findings from a qualitative Australian study similarly suggest that mental health care providers welcome the participation of pharmacists in mental health teams’ meetings and medication review and valued the provision of information about medications by pharmacists to clients, caregivers, and families [19]. …”

Section: Discussionmentioning

confidence: 99%

A Survey of Psychiatrists’ Expectations of Clinical Pharmacists in Riyadh, Saudi Arabia

Al-Aqeel

Al-sabhan

Aljumah³

2012

Med Princ Pract

View full text Add to dashboard Cite

Objectives: To measure psychiatrists’ experience and their expectations of the role of clinical pharmacists in Riyadh, Saudi Arabia. Subjects and Methods: The psychiatrists’ experience and their expectations were collected using a 4-part self-completed questionnaire: (a) demographic information, (b) psychiatrists’ current expectations of the roles of pharmacists, (c) psychiatrists’ actual experience with pharmacists, and (d) psychiatrists’ future expectations of pharmacists’ roles. Each part included a set of statements for which respondents were asked to indicate their level of agreement using a 5-point Likert scale. Results: Of the 102 questionnaires delivered to the Department of Psychiatry at 7 hospitals, 77 were returned, representing a response rate of 75%. 59 (77%) psychiatrists expected pharmacists to take personal responsibility for resolving any drug-related problems; 62 (81%) expected them to maintain a complete medication profile, and 58 (75%) expected them to educate patients about the safety and appropriate use of their medication. From their current experience with pharmacists, respondents indicated that pharmacists routinely counsel patients (33, 43%), inform them about the most cost-effective alternative (37, 48%), and discuss with them the therapeutic value of the drugs (37, 48%). 49 (63%) of respondents agreed that in the future, pharmacists should routinely adjust the drug therapy for patients under protocol approved by the physician, and 51 (66%) felt that pharmacists should share legal responsibility for clinical outcomes. Conclusion: Psychiatrists in Riyadh had great expectations of clinical pharmacists to take personal responsibility for resolving drug-related problems they discovered and to assist in designing drug therapy treatment plans. The psychiatrists’ current experience with pharmacists did not, in some cases, meet their expectations.

show abstract

“…For instance, the Pharmacy Asthma Program was launched in 1997, the Pharmacy Diabetes Program in 2000, and the Pharmacy Heart Program in 2005. Within such programs, pharmacists collaborate with physicians, nurses, and other health care professionals at the local level [22]. However, at present, none of these services are remunerated.…”

Section: Specific Ppsmentioning

confidence: 99%